Gene Modified Donor T-cells after TCR Alpha Beta Positive Depleted Stem Cell Transplant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gene Modified Donor T-cells after TCR Alpha Beta Positive Depleted Stem Cell Transplant, covering 2022-07-12 to 2022-07-12. Get the full timeline:
Most recent: Clinical Trial Update: Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant [Phase 1, Phase 2]